期刊文献+

医学生对中成药种类熟悉情况调查分析

Investigation on Medical Students′ Acquaintance with the Sorts of Chinese Patent Drugs
下载PDF
导出
摘要 目的:全面了解我校医学生对中成药种类的熟悉情况,为中成药知识宣传与教育提供理论依据。方法:以国家基本药物目录(中成药)为标准,对我校临床专业1000名学生进行中成药种类熟悉情况调查。结果:回收合格问卷980份,60%一70%以上的医学生中成药知识缺乏。同时,熟悉频率最高的前10种中成药为感冒类、止咳类中成药制剂,以及药名易记的中成药制剂等。结论:我校医学生中成药知识缺乏,需加强中成药知识的宣传与教育。 Objective: To provide theoretical evidence for the propagation and education of Chinese patent drug knowledge by completely knowing medical students' acquaintance with the sorts of Chinese patent drugs. Method: The conditions of 1 000 medical students' acquaintance in our school were investigated based on the standard of national essential drug list (Chinese patent drugs).Result: Altogether 980 pieces of qualified questionnaires were returned, 60%-70% of medical students lacked Chinese patent drug knowledge. At the same time, the top ten Chinese patent drugs with high acquaintance frequency were the ones for common cold, stopping cough, the name of the drugs easily to remember and others. Conclusion: Due to the lack of Chinese patent drug knowledge, we should enhance the propagation and education of Chinese patent drug knowledge for medical students.
作者 杜发强
出处 《西部中医药》 2013年第11期82-83,共2页 Western Journal of Traditional Chinese Medicine
关键词 医学生 中成药 种类 熟悉情况 调查分析 medical students Chinese patent drugs sorts acquaintance investigation
  • 相关文献

参考文献3

二级参考文献23

  • 1刘甲兴,芮磊.亚宁定与酚妥拉明治疗高血压急症的降压疗效比较[J].海南医学,2005,16(8):69-70. 被引量:1
  • 2杨晓晖,张力,吴桂芝,刘翠丽,杨乐.消渴丸的不良反应与合理应用[J].中国药物警戒,2006,3(2):76-80. 被引量:11
  • 3陆德澄,侯建民,汤永祥,芮涛,慈书平,陈志梅.静脉注射卡托普利和酚妥拉明治疗重症高血压病的比较[J].新药与临床,1996,15(6):328-330. 被引量:5
  • 4WHO. The selection of essential drugs : report of a WHO expert committee (WHO Technical Report Series 615) [M]. Geneva: World Health Organization, 1977 : 28~33.
  • 5WHO. The use of essential drugs : second report of the WHO expert committee (WHO Technical Report Series 722) [M]. Geneva: World Health Organization, 1985:7~8.
  • 6WHO. The use of essential drugs :ninth report of the WHO expert committee (WHO Technical Report Series 895) [M]. Geneva. World Health Organization, 2000 : 4~ 5.
  • 7WHO. The selection and use of essential drugs, report of the WHO expert committee ( WHO Technical Report Series 914) [M]. Geneva: World Health Organization, 2002 : 5 ~ 7.
  • 8Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [EB/OL]. www. cochrane-handbook.org. 2010-03-20.
  • 9Faunce TA. Toward a treaty on safety and cost(effectiveness of pharmaceuticals and medical devices: enhancing an endangered global public good[J]. Globalization and Health, 2006, 2 : 5.
  • 10Berger ML, Teutsch S. Cost-effectiveness analysis: from science to application[J]. Medical Care, 2005, 43 (7 suppl) : 49.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部